MedPath

Extended Phenytoin Sodium

Extended Phenytoin Sodium, USP Rx Only These highlights do not include all the information needed to use EXTENDED PHENYTOIN SODIUM CAPSULES safely and effectively. See full prescribing information for EXTENDED PHENYTOIN SODIUM CAPSULES Initial U.S. Approval: 1953

Approved
Approval ID

f163208c-25e7-415b-ae17-9f5f5870e6e8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 12, 2020

Manufacturers
FDA

Aphena Pharma Solutions - Tennessee, LLC

DUNS: 128385585

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Phenytoin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71610-479
Application NumberANDA040765
Product Classification
M
Marketing Category
C73584
G
Generic Name
Phenytoin Sodium
Product Specifications
Route of AdministrationORAL
Effective DateNovember 12, 2020
FDA Product Classification

INGREDIENTS (1)

PHENYTOIN SODIUMActive
Quantity: 100 mg in 1 1
Code: 4182431BJH
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Extended Phenytoin Sodium - FDA Drug Approval Details